Karen (Oerter) Klein MD
Board-certified Pediatric Endocrinologist at Rady Children's Hospital-San Diego and Clinical Professor of Pediatrics at UC San Diego School of Medicine
Join to View Full Profile
8110 Birmingham WaySan Diego, CA 92123
Phone+1 858-966-4032
Fax+1 858-309-6301
Dr. Klein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1988 - 1990
Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1985 - 1988
Pennsylvania State University College of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1993 - 2026
DE State Medical License 1994 - 2003
NJ State Medical License 1999 - 2001
PA State Medical License 1986 - 2000
MD State Medical License 1988 - 1999
American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty Start of enrollment: 2015 Aug 31
Publications & Presentations
PubMed
- 1 citationsPrevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47,XXX): Results from the InsighTS Registry.Natalia Klamut, Samantha Bothwell, Alexandra E Carl, Vaneeta Bamba, Jennifer R Law
American Journal of Medical Genetics. Part A. 2024-12-01 - Timing of onset of menses after GnRH agonist treatment for central precocious puberty.Karen O Klein, Marcela Vargas Trujillo, Sanja Dragnic, Stephen Van Komen, Moming Li
Journal of Pediatric Endocrinology & Metabolism. 2024-08-27 - 32 citationsClinical practice guidelines for the care of girls and women with Turner syndrome.Claus H Gravholt, Niels H Andersen, Sophie Christin-Maitre, Shanlee M Davis, Anthonie Duijnhouwer
European Journal of Endocrinology. 2024-06-05
Press Mentions
- Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur(TM), Triptorelin 6-Month Formulation, FoMay 1st, 2018
FDA: Triptorelin Slows Central Precocious PubertyJuly 10th, 2017
FDA Approves Triptodur for Treatment of Early PubertyJune 30th, 2017
Grant Support
- Recombinant Tissue Plasminogen Activator For Treatment Of Livedoid VasculitisNational Center For Research Resources1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
